Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
DIA:CONN（디아콘）is a blood glucose management platform for people with diabetes, caregivers, and healthcare professionals. It covers the DIA:CONN App, the G8 platform-type insulin pump, the P8 electric smart insulin pen, and the Care Web cloud monitoring service. Its positioning is closer to “medical device + mobile app + remote monitoring platform” than to a general-purpose AI tool.
The platform connects to the G8 and P8 via Bluetooth Low Energy. The app can display shared blood glucose readings, sync injection history and usage information, and configure and control injections on the G8. Its key intelligent feature is the Bolus Calculator, which can factor in active insulin, current blood glucose, and trending glucose levels to recommend insulin dosage and carbohydrate intake. The P8 can also work with CGMs and self-monitoring blood glucose meters to help patients plan injections and meals. Care Web uses data uploaded from the app to let healthcare providers remotely view blood glucose, diet, and insulin injection records, as well as analyze and save them in chart form.
The collected text does not disclose pricing for the hardware, app, or Care Web, nor does it mention subscription models, free trials, or insurance coverage. The only related item is a “Purchase” entry for the P8. Therefore, procurement costs, service fees, and regional sales policies still need to be confirmed with the manufacturer.
The advantages are its high level of software-hardware integration, covering patient-side insulin delivery, data recording, and doctor-side remote monitoring. The combination of bolus calculation and glucose trends is valuable for refined day-to-day management. The page also lists medical device review and certification information. Its limitations are that it does not disclose details about AI models or clinical algorithms, so it should not be understood as a generative AI product. Some features depend on dedicated G8/P8 devices, and pump functions will not be enabled if the device is not registered. In terms of privacy, although encrypted transmission and patient consent are mentioned, a complete compliance explanation is lacking.
It is suitable for people with diabetes who need management through an insulin pump or smart insulin pen, as well as medical institutions that want to remotely track patients’ blood glucose and injection records. It is not suitable for users looking for general AI health Q&A, standalone blood glucose analysis software, or an open API platform.
The main text does not state whether access, registration, purchase, after-sales support, or Chinese-language support is available in mainland China. The page is in Korean, so china_access is assessed as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on diaconn.com official site.
diaconn.com is an South Korea Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach diaconn.com directly.